Figure 10 — Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer

Research Paper|Volume 15, Issue 18|pp. 9779–9796

Pan-cancer analysis and experimental validation identify ndc1 as a potential immunological, prognostic and therapeutic biomarker in pancreatic cancer

Back to articleFigure 10(10 of 11)

100%

Figure 10.(A) Nomogram established for prognosis of PAAD. (B) Calibration curves for 1- and 3-year survival of PAAD. (C) Chemosensitivity of NDC1 in PAAD.